Jiangsu Realline Biotechnology, located in China Medical City, Taizhou, has been the guardian of equipment for local biopharmaceutical enterprises.

The Jiangsu Department of Housing and Urban-Rural Development has announced the 2026 demonstration projects focused on characteristic countryside construction, with one from Taizhou Medical High-tech Zone included in this initiative.

Jiangsu Weihe Biotechnology received good news that its independently developed human leukocyte antigen (HLA) genotyping test kit (fluorescence PCR method) has been approved for the market.

The first and second batches of provincial diagnostic service providers for artificial intelligence and manufacturing have been released, with five enterprises from the zone included.

The Taizhou Medical High-Tech Zone has leveraged the Yangtze River Delta "One-Stop Service" remote virtual window to enhance cross-regional administrative services.

Join us in Huzhuang town, Taizhou, Jiangsu province, this summer to enjoy the delightful experience of fruit picking.

The first smart health station in Taizhou has been put into use in Zhongrun community, where the elderly population is 30 percent.

At the 2026 Digestive Disease Week in the United States, Yangtze River Pharmaceutical Group achieved a significant milestone.